Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -2% | 8.2% | 15.1% |
| Success rate | 51% | 68% | 82% |
| Transactions |
16
100% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Director | Kaleido Biosciences Inc | None - |
| President and Chief Executive Officer, Director | Spyre Therapeutics Inc | Oct. 10, 2019 - |
| President, Chief Executive Officer, Director | Spyre Therapeutics Inc | July 1, 2018 - Oct. 10, 2019 |
| Interim Chief Executive Officer, Director | Spyre Therapeutics Inc | July 18, 2017 - July 1, 2018 |
| Director, Interim Chief Medical Officer | Spyre Therapeutics Inc | April 1, 2017 - July 1, 2017 |
| Independent Director | Spyre Therapeutics Inc | March 1, 2016 - April 1, 2017 |
Search